Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Revenue: 2018-2024

Historic Revenue for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to -$2.5 million.

  • Revolution Medicines' Revenue was N/A to -$11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.7 million, marking a year-over-year change of. This contributed to the annual value of -$2.5 million for FY2024, which is 121.83% down from last year.
  • Revolution Medicines' Revenue amounted to -$2.5 million in FY2024, which was down 121.83% from $11.6 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Revenue ranged from a high of $43.0 million in FY2020 and a low of -$2.5 million during FY2024.
  • In the last 3 years, Revolution Medicines' Revenue had a median value of $11.6 million in 2023 and averaged $14.8 million.
  • Its Revenue has fluctuated over the past 5 years, first rose by 20.38% in 2022, then slumped by 121.83% in 2024.
  • Yearly analysis of 5 years shows Revolution Medicines' Revenue stood at $43.0 million in 2020, then crashed by 31.62% to $29.4 million in 2021, then grew by 20.38% to $35.4 million in 2022, then slumped by 67.27% to $11.6 million in 2023, then slumped by 121.83% to -$2.5 million in 2024.